View ValuationFufeng Group 향후 성장Future 기준 점검 1/6Fufeng Group (는) 각각 연간 9.5% 및 4.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 9.5% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 13% 로 예상됩니다.핵심 정보9.5%이익 성장률9.49%EPS 성장률Chemicals 이익 성장40.8%매출 성장률4.8%향후 자기자본이익률13.00%애널리스트 커버리지Low마지막 업데이트29 Apr 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updatesDeclared Dividend • May 20Final dividend of HK$0.12 announcedShareholders will receive a dividend of HK$0.12. Ex-date: 2nd June 2026 Payment date: 30th June 2026 Dividend yield will be 8.1%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (32% earnings payout ratio) but not covered by cash flows (377% cash payout ratio). The dividend has increased by an average of 22% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 31% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Board Change • May 20Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Fiona Li was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.공시 • Mar 26Fufeng Group Limited, Annual General Meeting, May 29, 2026Fufeng Group Limited, Annual General Meeting, May 29, 2026.공시 • Mar 16Fufeng Group Limited to Report Fiscal Year 2025 Results on Mar 26, 2026Fufeng Group Limited announced that they will report fiscal year 2025 results on Mar 26, 2026공시 • Aug 18Fufeng Group Limited to Report First Half, 2025 Results on Aug 28, 2025Fufeng Group Limited announced that they will report first half, 2025 results on Aug 28, 2025공시 • May 29+ 1 more updateFufeng Group Limited Approves Special Final Dividend for the Year Ended 31 December 2024, Payable on or about 27 June 2025Fufeng Group Limited at its AGM held on May 29, 2025, approved special final dividend of 3 Hong Kong cents per share for the year ended 31 December 2024. The register of members of the Company will be closed from 4 June 2025 to 6 June 2025 (both dates inclusive), during which no transfer of shares will be registered. In order to qualify for the final dividend, all transfers of shares accompanied by the relevant share certificates must be lodged with the Company's branch registrar in Hong Kong, Tricor Investor Services Limited at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong not later than 4:30 p.m. on 3 June 2025. Such dividend will be distributed on or about 27 June 2025 to Shareholders whose names appear on the register of members of the Company on 6 June 2025.공시 • Mar 28Fufeng Group Limited, Annual General Meeting, May 29, 2025Fufeng Group Limited, Annual General Meeting, May 29, 2025.공시 • Mar 18Fufeng Group Limited to Report Fiscal Year 2024 Results on Mar 28, 2025Fufeng Group Limited announced that they will report fiscal year 2024 results on Mar 28, 2025Declared Dividend • Sep 01First half dividend of HK$0.18 announcedShareholders will receive a dividend of HK$0.18. Ex-date: 10th September 2024 Payment date: 30th September 2024 Dividend yield will be 12%, which is higher than the industry average of 8.1%. Sustainability & Growth Dividend is covered by earnings (33% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 44% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Aug 31First half 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.61 in 1H 2023)First half 2024 results: EPS: CN¥0.41 (down from CN¥0.61 in 1H 2023). Revenue: CN¥13.4b (down 1.6% from 1H 2023). Net income: CN¥1.04b (down 32% from 1H 2023). Profit margin: 7.8% (down from 11% in 1H 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.공시 • Aug 29+ 2 more updatesFufeng Group Limited Announces Special Interim Dividend for the Six Months Ended 30 June 2024, Payable on 30 September 2024Fufeng Group Limited announced special interim dividend of HKD 0.02 per share for the six months ended 30 June 2024. Ex-dividend date is 10 September 2024. Record date is 13 September 2024. Payment date is 30 September 2024.공시 • Aug 20Fufeng Group Limited to Report First Half, 2024 Results on Aug 29, 2024Fufeng Group Limited announced that they will report first half, 2024 results on Aug 29, 2024Valuation Update With 7 Day Price Move • Jul 05Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to HK$4.43, the stock trades at a forward P/E ratio of 3x. Average forward P/E is 9x in the Chemicals industry in Hong Kong. Total returns to shareholders of 148% over the past three years.Upcoming Dividend • May 27Upcoming dividend of HK$0.35 per shareEligible shareholders must have bought the stock before 03 June 2024. Payment date: 28 June 2024. Payout ratio is a comfortable 33% but the company is not cash flow positive. Trailing yield: 7.2%. Lower than top quartile of Hong Kong dividend payers (7.6%). Higher than average of industry peers (4.7%).공시 • Mar 28Fufeng Group Limited, Annual General Meeting, May 30, 2024Fufeng Group Limited, Annual General Meeting, May 30, 2024.Reported Earnings • Mar 28Full year 2023 earnings released: EPS: CN¥1.24 (vs CN¥1.52 in FY 2022)Full year 2023 results: EPS: CN¥1.24 (down from CN¥1.52 in FY 2022). Revenue: CN¥28.0b (up 1.9% from FY 2022). Net income: CN¥3.14b (down 19% from FY 2022). Profit margin: 11% (down from 14% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.5% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.공시 • Mar 27Fufeng Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024Fufeng Group Limited proposed final dividend of HKD 0.22 per share for the year ended 31 December 2023. Date of shareholders' approval is 30 May 2024. Ex-dividend date is 03 June 2024. Record date is 07 June 2024. Payment date is 28 June 2024.공시 • Mar 16Fufeng Group Limited to Report Fiscal Year 2023 Results on Mar 27, 2024Fufeng Group Limited announced that they will report fiscal year 2023 results on Mar 27, 2024Upcoming Dividend • Sep 11Upcoming dividend of HK$0.23 per share at 13% yieldEligible shareholders must have bought the stock before 18 September 2023. Payment date: 13 October 2023. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 13%. Within top quartile of Hong Kong dividend payers (7.7%). Higher than average of industry peers (7.6%).Reported Earnings • Sep 01First half 2023 earnings released: EPS: CN¥0.61 (vs CN¥0.80 in 1H 2022)First half 2023 results: EPS: CN¥0.61 (down from CN¥0.80 in 1H 2022). Revenue: CN¥13.6b (up 5.0% from 1H 2022). Net income: CN¥1.54b (down 24% from 1H 2022). Profit margin: 11% (down from 16% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.공시 • Aug 31Fufeng Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 13 October 2023Fufeng Group Limited announced Interim Dividend of HKD 0.23 per share for the six months ended 30 June 2023. Record date is 22 September 2023. Payment date is 13 October 2023. Ex-dividend date is 18 September 2023.공시 • Aug 19Fufeng Group Limited to Report First Half, 2023 Results on Aug 30, 2023Fufeng Group Limited announced that they will report first half, 2023 results on Aug 30, 2023공시 • Aug 01Fufeng Group Limited Announces Management Changes, Effect from 1 August 2023The board of directors of Fufeng Group Limited announced that Mr. Lee Wai Yin (Mr. Lee) has tendered his resignation as company secretary and authorised representative of the Company with effect from 1 August 2023. The Board announced that Mr. Yau Wing Yiu (Mr. Yau) will be appointed as the company secretary and authorised representative of the Company with effect from 1 August 2023. Mr. Yau joined the Group as chief financial officer since June 2021. Mr. Yau is an associate member of the Hong Kong Institute of Certified Public Accountants and a fellow member of the Association of Chartered Certified Accountants. The biography of Mr. Yau could be referenced to the 2022 annual report of the Company.Upcoming Dividend • May 29Upcoming dividend of HK$0.33 per share at 13% yieldEligible shareholders must have bought the stock before 05 June 2023. Payment date: 30 June 2023. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 13%. Within top quartile of Hong Kong dividend payers (7.7%). Higher than average of industry peers (7.3%).공시 • May 26+ 1 more updateFufeng Group Limited Approves Special Final Dividend for the Year Ended 31 December 2022Fufeng Group Limited's AGM, held on May 25, 2023, approved special final dividend of HK 4.1 cents per share for the year ended 31 December 2022.Reported Earnings • Mar 31Full year 2022 earnings released: EPS: CN¥1.52 (vs CN¥0.51 in FY 2021)Full year 2022 results: EPS: CN¥1.52 (up from CN¥0.51 in FY 2021). Revenue: CN¥27.5b (up 28% from FY 2021). Net income: CN¥3.86b (up 202% from FY 2021). Profit margin: 14% (up from 5.9% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 31First half 2022 earnings released: EPS: CN¥0.80 (vs CN¥0.23 in 1H 2021)First half 2022 results: EPS: CN¥0.80 (up from CN¥0.23 in 1H 2021). Revenue: CN¥12.9b (up 36% from 1H 2021). Net income: CN¥2.03b (up 243% from 1H 2021). Profit margin: 16% (up from 6.2% in 1H 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 9.7% while the Chemicals industry in Hong Kong is not expected to grow. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 5% per year.Valuation Update With 7 Day Price Move • Jul 03Investor sentiment improved over the past weekAfter last week's 21% share price gain to HK$5.03, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 39% over the past three years.Valuation Update With 7 Day Price Move • Jun 18Investor sentiment improved over the past weekAfter last week's 16% share price gain to HK$4.33, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 27% over the past three years.Upcoming Dividend • May 30Upcoming dividend of HK$0.12 per shareEligible shareholders must have bought the stock before 06 June 2022. Payment date: 30 June 2022. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 5.1%. Lower than top quartile of Hong Kong dividend payers (7.8%). In line with average of industry peers (5.4%).Reported Earnings • Apr 27Full year 2021 earnings released: EPS: CN¥0.51 (vs CN¥0.25 in FY 2020)Full year 2021 results: EPS: CN¥0.51 (up from CN¥0.25 in FY 2020). Revenue: CN¥21.5b (up 29% from FY 2020). Net income: CN¥1.28b (up 103% from FY 2020). Profit margin: 5.9% (up from 3.8% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 19%, compared to a 12% growth forecast for the industry in Hong Kong. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.Recent Insider Transactions • Apr 06Principal Founder & Executive Chairman recently bought HK$3.2m worth of stockOn the 1st of April, Xuechun Li bought around 1m shares on-market at roughly HK$3.18 per share. This was the largest purchase by an insider in the last 3 months. This was Xuechun's only on-market trade for the last 12 months.Reported Earnings • Apr 01Full year 2021 earnings released: EPS: CN¥0.51 (vs CN¥0.25 in FY 2020)Full year 2021 results: EPS: CN¥0.51 (up from CN¥0.25 in FY 2020). Revenue: CN¥21.5b (up 29% from FY 2020). Net income: CN¥1.28b (up 103% from FY 2020). Profit margin: 5.9% (up from 3.8% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 3.2% compared to a 8.3% growth forecast for the industry in Hong Kong. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improved over the past weekAfter last week's 17% share price gain to HK$2.87, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 6x in the Chemicals industry in Hong Kong. Total loss to shareholders of 20% over the past three years.Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to HK$3.12, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 14% over the past three years.Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improved over the past weekAfter last week's 19% share price gain to HK$3.12, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 17% over the past three years.Upcoming Dividend • Sep 06Upcoming dividend of HK$0.098 per shareEligible shareholders must have bought the stock before 13 September 2021. Payment date: 30 September 2021. Trailing yield: 4.8%. Lower than top quartile of Hong Kong dividend payers (6.6%). Higher than average of industry peers (2.9%).Reported Earnings • Sep 03First half 2021 earnings released: EPS CN¥0.23 (vs CN¥0.15 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: CN¥9.52b (up 17% from 1H 2020). Net income: CN¥591.0m (up 56% from 1H 2020). Profit margin: 6.2% (up from 4.6% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.Valuation Update With 7 Day Price Move • Sep 02Investor sentiment improved over the past weekAfter last week's 16% share price gain to HK$2.92, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 6x in the Chemicals industry in Hong Kong. Total loss to shareholders of 6.2% over the past three years.Executive Departure • Jun 16Chief Financial Officer Yuan Chen has left the companyOn the 15th of June, Yuan Chen's tenure as Chief Financial Officer ended after 3.9 years in the role. We don't have any record of a personal shareholding under Yuan's name. A total of 3 executives have left over the last 12 months. The current median tenure of the management team is 3.92 years.Upcoming Dividend • May 31Upcoming dividend of HK$0.041 per shareEligible shareholders must have bought the stock before 07 June 2021. Payment date: 30 June 2021. Trailing yield: 3.2%. Lower than top quartile of Hong Kong dividend payers (6.0%). Lower than average of industry peers (3.6%).Reported Earnings • Apr 25Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.45 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥16.7b (up 3.2% from FY 2019). Net income: CN¥629.9m (down 45% from FY 2019). Profit margin: 3.8% (down from 7.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 13% per year.Executive Departure • Apr 01Independent Non-Executive Director has left the companyOn the 1st of April, Zheng Yu's tenure as Independent Non-Executive Director ended after 8.3 years in the role. We don't have any record of a personal shareholding under Zheng's name. A total of 3 executives have left over the last 12 months.Reported Earnings • Mar 26Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.45 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥16.7b (up 3.2% from FY 2019). Net income: CN¥629.9m (down 45% from FY 2019). Profit margin: 3.8% (down from 7.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 14% per year.Is New 90 Day High Low • Feb 20New 90-day high: HK$3.76The company is up 33% from its price of HK$2.82 on 20 November 2020. The Hong Kong market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 32% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is HK$12.17 per share.Valuation Update With 7 Day Price Move • Feb 02Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥3.64, the stock is trading at a trailing P/E ratio of 8.5x, up from the previous P/E ratio of 7.3x. This compares to an average P/E of 9x in the Chemicals industry in Hong Kong. Total return to shareholders over the past three years is a loss of 14%.Is New 90 Day High Low • Jan 18New 90-day high: HK$3.10The company is up 25% from its price of HK$2.48 on 21 October 2020. The Hong Kong market is up 16% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 27% over the same period.Is New 90 Day High Low • Nov 16New 90-day high: HK$2.80The company is up 4.0% from its price of HK$2.69 on 18 August 2020. The Hong Kong market is also up 4.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is down 4.0% over the same period.Recent Insider Transactions • Oct 06CEO & Executive Director recently bought HK$1.3m worth of stockOn the 30th of September, Deheng Li bought around 541k shares on-market at roughly HK$2.40 per share. This was the largest purchase by an insider in the last 3 months. This was Deheng's only on-market trade for the last 12 months.Is New 90 Day High Low • Sep 22New 90-day low: HK$2.43The company is down 5.0% from its price of HK$2.56 on 24 June 2020. The Hong Kong market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is HK$10.93 per share.이익 및 매출 성장 예측SZSC:546 - 애널리스트 향후 추정치 및 과거 재무 데이터 (CNY Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/202832,1993,212N/A2,882312/31/202730,4242,630N/A5,034412/31/202628,8582,201N/A3,401412/31/202527,8792,4652412,911N/A9/30/202528,1142,7644682,262N/A6/30/202528,3493,0636941,613N/A3/31/202528,0532,6881,2142,284N/A12/31/202427,7572,3121,7342,955N/A9/30/202427,7762,4801,4213,147N/A6/30/202427,7952,6471,1083,338N/A3/31/202427,9012,8962452,521N/A12/31/202328,0073,144-6191,705N/A9/30/202328,0653,2597952,744N/A6/30/202328,1243,3732,2093,782N/A3/31/202327,7993,6172,3913,691N/A12/31/202227,4753,8612,5723,600N/A9/30/202226,2123,2882,5983,357N/A6/30/202224,9502,7162,6243,114N/A3/31/202223,2451,9982,4482,944N/A12/31/202121,5401,2812,2722,774N/A9/30/202119,7911,0617651,426N/A6/30/202118,043842-74277N/A3/31/202117,367736-771141N/A12/31/202016,691630-799206N/A9/30/202016,663767-400751N/A6/30/202016,636904-21,297N/A3/31/202016,4031,021-3781,095N/A12/31/201916,1711,137-754892N/A9/30/201915,5141,640N/A1,357N/A6/30/201914,8582,143N/A1,821N/A3/31/201914,3111,994N/A1,666N/A12/31/201813,7651,845N/A1,510N/A9/30/201813,5991,450N/A1,401N/A6/30/201813,4331,055N/A1,293N/A3/31/201813,2331,219N/A1,248N/A12/31/201713,0341,382N/A1,202N/A9/30/201712,7671,384N/A1,138N/A6/30/201712,5011,385N/A1,073N/A3/31/201712,1521,239N/A1,582N/A12/31/201611,8031,093N/A2,090N/A9/30/201611,455773N/A2,162N/A6/30/201611,107453N/A2,235N/A3/31/201611,166485N/A1,692N/A12/31/201511,226516N/A1,149N/A9/30/201511,224641N/A1,157N/A6/30/201511,222765N/A1,165N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: 546 의 연간 예상 수익 증가율(9.5%)이 saving rate(3%)보다 높습니다.수익 vs 시장: 546 의 연간 수익(9.5%)이 Hong Kong 시장(12.5%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: 546 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: 546 의 수익(연간 4.8%)이 Hong Kong 시장(연간 8.6%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: 546 의 수익(연간 4.8%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: 546의 자본 수익률은 3년 후 13%로 낮을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 17:29종가2026/05/21 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Fufeng Group Limited는 15명의 분석가가 다루고 있습니다. 이 중 4명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Lei YangCGS Internationalnull nullChina International Capital Corporation LimitedYilin HouChina International Capital Corporation Limited12명의 분석가 더 보기
Declared Dividend • May 20Final dividend of HK$0.12 announcedShareholders will receive a dividend of HK$0.12. Ex-date: 2nd June 2026 Payment date: 30th June 2026 Dividend yield will be 8.1%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (32% earnings payout ratio) but not covered by cash flows (377% cash payout ratio). The dividend has increased by an average of 22% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 31% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Board Change • May 20Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. Independent Non-Executive Director Fiona Li was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
공시 • Mar 26Fufeng Group Limited, Annual General Meeting, May 29, 2026Fufeng Group Limited, Annual General Meeting, May 29, 2026.
공시 • Mar 16Fufeng Group Limited to Report Fiscal Year 2025 Results on Mar 26, 2026Fufeng Group Limited announced that they will report fiscal year 2025 results on Mar 26, 2026
공시 • Aug 18Fufeng Group Limited to Report First Half, 2025 Results on Aug 28, 2025Fufeng Group Limited announced that they will report first half, 2025 results on Aug 28, 2025
공시 • May 29+ 1 more updateFufeng Group Limited Approves Special Final Dividend for the Year Ended 31 December 2024, Payable on or about 27 June 2025Fufeng Group Limited at its AGM held on May 29, 2025, approved special final dividend of 3 Hong Kong cents per share for the year ended 31 December 2024. The register of members of the Company will be closed from 4 June 2025 to 6 June 2025 (both dates inclusive), during which no transfer of shares will be registered. In order to qualify for the final dividend, all transfers of shares accompanied by the relevant share certificates must be lodged with the Company's branch registrar in Hong Kong, Tricor Investor Services Limited at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong not later than 4:30 p.m. on 3 June 2025. Such dividend will be distributed on or about 27 June 2025 to Shareholders whose names appear on the register of members of the Company on 6 June 2025.
공시 • Mar 28Fufeng Group Limited, Annual General Meeting, May 29, 2025Fufeng Group Limited, Annual General Meeting, May 29, 2025.
공시 • Mar 18Fufeng Group Limited to Report Fiscal Year 2024 Results on Mar 28, 2025Fufeng Group Limited announced that they will report fiscal year 2024 results on Mar 28, 2025
Declared Dividend • Sep 01First half dividend of HK$0.18 announcedShareholders will receive a dividend of HK$0.18. Ex-date: 10th September 2024 Payment date: 30th September 2024 Dividend yield will be 12%, which is higher than the industry average of 8.1%. Sustainability & Growth Dividend is covered by earnings (33% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 21% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 44% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Aug 31First half 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.61 in 1H 2023)First half 2024 results: EPS: CN¥0.41 (down from CN¥0.61 in 1H 2023). Revenue: CN¥13.4b (down 1.6% from 1H 2023). Net income: CN¥1.04b (down 32% from 1H 2023). Profit margin: 7.8% (down from 11% in 1H 2023). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth.
공시 • Aug 29+ 2 more updatesFufeng Group Limited Announces Special Interim Dividend for the Six Months Ended 30 June 2024, Payable on 30 September 2024Fufeng Group Limited announced special interim dividend of HKD 0.02 per share for the six months ended 30 June 2024. Ex-dividend date is 10 September 2024. Record date is 13 September 2024. Payment date is 30 September 2024.
공시 • Aug 20Fufeng Group Limited to Report First Half, 2024 Results on Aug 29, 2024Fufeng Group Limited announced that they will report first half, 2024 results on Aug 29, 2024
Valuation Update With 7 Day Price Move • Jul 05Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to HK$4.43, the stock trades at a forward P/E ratio of 3x. Average forward P/E is 9x in the Chemicals industry in Hong Kong. Total returns to shareholders of 148% over the past three years.
Upcoming Dividend • May 27Upcoming dividend of HK$0.35 per shareEligible shareholders must have bought the stock before 03 June 2024. Payment date: 28 June 2024. Payout ratio is a comfortable 33% but the company is not cash flow positive. Trailing yield: 7.2%. Lower than top quartile of Hong Kong dividend payers (7.6%). Higher than average of industry peers (4.7%).
공시 • Mar 28Fufeng Group Limited, Annual General Meeting, May 30, 2024Fufeng Group Limited, Annual General Meeting, May 30, 2024.
Reported Earnings • Mar 28Full year 2023 earnings released: EPS: CN¥1.24 (vs CN¥1.52 in FY 2022)Full year 2023 results: EPS: CN¥1.24 (down from CN¥1.52 in FY 2022). Revenue: CN¥28.0b (up 1.9% from FY 2022). Net income: CN¥3.14b (down 19% from FY 2022). Profit margin: 11% (down from 14% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.5% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth.
공시 • Mar 27Fufeng Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024Fufeng Group Limited proposed final dividend of HKD 0.22 per share for the year ended 31 December 2023. Date of shareholders' approval is 30 May 2024. Ex-dividend date is 03 June 2024. Record date is 07 June 2024. Payment date is 28 June 2024.
공시 • Mar 16Fufeng Group Limited to Report Fiscal Year 2023 Results on Mar 27, 2024Fufeng Group Limited announced that they will report fiscal year 2023 results on Mar 27, 2024
Upcoming Dividend • Sep 11Upcoming dividend of HK$0.23 per share at 13% yieldEligible shareholders must have bought the stock before 18 September 2023. Payment date: 13 October 2023. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 13%. Within top quartile of Hong Kong dividend payers (7.7%). Higher than average of industry peers (7.6%).
Reported Earnings • Sep 01First half 2023 earnings released: EPS: CN¥0.61 (vs CN¥0.80 in 1H 2022)First half 2023 results: EPS: CN¥0.61 (down from CN¥0.80 in 1H 2022). Revenue: CN¥13.6b (up 5.0% from 1H 2022). Net income: CN¥1.54b (down 24% from 1H 2022). Profit margin: 11% (down from 16% in 1H 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 7.5% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
공시 • Aug 31Fufeng Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 13 October 2023Fufeng Group Limited announced Interim Dividend of HKD 0.23 per share for the six months ended 30 June 2023. Record date is 22 September 2023. Payment date is 13 October 2023. Ex-dividend date is 18 September 2023.
공시 • Aug 19Fufeng Group Limited to Report First Half, 2023 Results on Aug 30, 2023Fufeng Group Limited announced that they will report first half, 2023 results on Aug 30, 2023
공시 • Aug 01Fufeng Group Limited Announces Management Changes, Effect from 1 August 2023The board of directors of Fufeng Group Limited announced that Mr. Lee Wai Yin (Mr. Lee) has tendered his resignation as company secretary and authorised representative of the Company with effect from 1 August 2023. The Board announced that Mr. Yau Wing Yiu (Mr. Yau) will be appointed as the company secretary and authorised representative of the Company with effect from 1 August 2023. Mr. Yau joined the Group as chief financial officer since June 2021. Mr. Yau is an associate member of the Hong Kong Institute of Certified Public Accountants and a fellow member of the Association of Chartered Certified Accountants. The biography of Mr. Yau could be referenced to the 2022 annual report of the Company.
Upcoming Dividend • May 29Upcoming dividend of HK$0.33 per share at 13% yieldEligible shareholders must have bought the stock before 05 June 2023. Payment date: 30 June 2023. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 13%. Within top quartile of Hong Kong dividend payers (7.7%). Higher than average of industry peers (7.3%).
공시 • May 26+ 1 more updateFufeng Group Limited Approves Special Final Dividend for the Year Ended 31 December 2022Fufeng Group Limited's AGM, held on May 25, 2023, approved special final dividend of HK 4.1 cents per share for the year ended 31 December 2022.
Reported Earnings • Mar 31Full year 2022 earnings released: EPS: CN¥1.52 (vs CN¥0.51 in FY 2021)Full year 2022 results: EPS: CN¥1.52 (up from CN¥0.51 in FY 2021). Revenue: CN¥27.5b (up 28% from FY 2021). Net income: CN¥3.86b (up 202% from FY 2021). Profit margin: 14% (up from 5.9% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Chemicals industry in Hong Kong. Over the last 3 years on average, earnings per share has increased by 57% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 31First half 2022 earnings released: EPS: CN¥0.80 (vs CN¥0.23 in 1H 2021)First half 2022 results: EPS: CN¥0.80 (up from CN¥0.23 in 1H 2021). Revenue: CN¥12.9b (up 36% from 1H 2021). Net income: CN¥2.03b (up 243% from 1H 2021). Profit margin: 16% (up from 6.2% in 1H 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 9.7% while the Chemicals industry in Hong Kong is not expected to grow. Over the last 3 years on average, earnings per share has increased by 10% per year whereas the company’s share price has increased by 5% per year.
Valuation Update With 7 Day Price Move • Jul 03Investor sentiment improved over the past weekAfter last week's 21% share price gain to HK$5.03, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 39% over the past three years.
Valuation Update With 7 Day Price Move • Jun 18Investor sentiment improved over the past weekAfter last week's 16% share price gain to HK$4.33, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 27% over the past three years.
Upcoming Dividend • May 30Upcoming dividend of HK$0.12 per shareEligible shareholders must have bought the stock before 06 June 2022. Payment date: 30 June 2022. Payout ratio is a comfortable 35% and this is well supported by cash flows. Trailing yield: 5.1%. Lower than top quartile of Hong Kong dividend payers (7.8%). In line with average of industry peers (5.4%).
Reported Earnings • Apr 27Full year 2021 earnings released: EPS: CN¥0.51 (vs CN¥0.25 in FY 2020)Full year 2021 results: EPS: CN¥0.51 (up from CN¥0.25 in FY 2020). Revenue: CN¥21.5b (up 29% from FY 2020). Net income: CN¥1.28b (up 103% from FY 2020). Profit margin: 5.9% (up from 3.8% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 19%, compared to a 12% growth forecast for the industry in Hong Kong. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
Recent Insider Transactions • Apr 06Principal Founder & Executive Chairman recently bought HK$3.2m worth of stockOn the 1st of April, Xuechun Li bought around 1m shares on-market at roughly HK$3.18 per share. This was the largest purchase by an insider in the last 3 months. This was Xuechun's only on-market trade for the last 12 months.
Reported Earnings • Apr 01Full year 2021 earnings released: EPS: CN¥0.51 (vs CN¥0.25 in FY 2020)Full year 2021 results: EPS: CN¥0.51 (up from CN¥0.25 in FY 2020). Revenue: CN¥21.5b (up 29% from FY 2020). Net income: CN¥1.28b (up 103% from FY 2020). Profit margin: 5.9% (up from 3.8% in FY 2020). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 3.2% compared to a 8.3% growth forecast for the industry in Hong Kong. Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Mar 22Investor sentiment improved over the past weekAfter last week's 17% share price gain to HK$2.87, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 6x in the Chemicals industry in Hong Kong. Total loss to shareholders of 20% over the past three years.
Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improved over the past weekAfter last week's 16% share price gain to HK$3.12, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 14% over the past three years.
Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improved over the past weekAfter last week's 19% share price gain to HK$3.12, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 5x in the Chemicals industry in Hong Kong. Total returns to shareholders of 17% over the past three years.
Upcoming Dividend • Sep 06Upcoming dividend of HK$0.098 per shareEligible shareholders must have bought the stock before 13 September 2021. Payment date: 30 September 2021. Trailing yield: 4.8%. Lower than top quartile of Hong Kong dividend payers (6.6%). Higher than average of industry peers (2.9%).
Reported Earnings • Sep 03First half 2021 earnings released: EPS CN¥0.23 (vs CN¥0.15 in 1H 2020)The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: CN¥9.52b (up 17% from 1H 2020). Net income: CN¥591.0m (up 56% from 1H 2020). Profit margin: 6.2% (up from 4.6% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 29% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
Valuation Update With 7 Day Price Move • Sep 02Investor sentiment improved over the past weekAfter last week's 16% share price gain to HK$2.92, the stock trades at a forward P/E ratio of 5x. Average forward P/E is 6x in the Chemicals industry in Hong Kong. Total loss to shareholders of 6.2% over the past three years.
Executive Departure • Jun 16Chief Financial Officer Yuan Chen has left the companyOn the 15th of June, Yuan Chen's tenure as Chief Financial Officer ended after 3.9 years in the role. We don't have any record of a personal shareholding under Yuan's name. A total of 3 executives have left over the last 12 months. The current median tenure of the management team is 3.92 years.
Upcoming Dividend • May 31Upcoming dividend of HK$0.041 per shareEligible shareholders must have bought the stock before 07 June 2021. Payment date: 30 June 2021. Trailing yield: 3.2%. Lower than top quartile of Hong Kong dividend payers (6.0%). Lower than average of industry peers (3.6%).
Reported Earnings • Apr 25Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.45 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥16.7b (up 3.2% from FY 2019). Net income: CN¥629.9m (down 45% from FY 2019). Profit margin: 3.8% (down from 7.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 13% per year.
Executive Departure • Apr 01Independent Non-Executive Director has left the companyOn the 1st of April, Zheng Yu's tenure as Independent Non-Executive Director ended after 8.3 years in the role. We don't have any record of a personal shareholding under Zheng's name. A total of 3 executives have left over the last 12 months.
Reported Earnings • Mar 26Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.45 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥16.7b (up 3.2% from FY 2019). Net income: CN¥629.9m (down 45% from FY 2019). Profit margin: 3.8% (down from 7.0% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 18% per year whereas the company’s share price has fallen by 14% per year.
Is New 90 Day High Low • Feb 20New 90-day high: HK$3.76The company is up 33% from its price of HK$2.82 on 20 November 2020. The Hong Kong market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 32% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is HK$12.17 per share.
Valuation Update With 7 Day Price Move • Feb 02Investor sentiment improved over the past weekAfter last week's 16% share price gain to CN¥3.64, the stock is trading at a trailing P/E ratio of 8.5x, up from the previous P/E ratio of 7.3x. This compares to an average P/E of 9x in the Chemicals industry in Hong Kong. Total return to shareholders over the past three years is a loss of 14%.
Is New 90 Day High Low • Jan 18New 90-day high: HK$3.10The company is up 25% from its price of HK$2.48 on 21 October 2020. The Hong Kong market is up 16% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 27% over the same period.
Is New 90 Day High Low • Nov 16New 90-day high: HK$2.80The company is up 4.0% from its price of HK$2.69 on 18 August 2020. The Hong Kong market is also up 4.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is down 4.0% over the same period.
Recent Insider Transactions • Oct 06CEO & Executive Director recently bought HK$1.3m worth of stockOn the 30th of September, Deheng Li bought around 541k shares on-market at roughly HK$2.40 per share. This was the largest purchase by an insider in the last 3 months. This was Deheng's only on-market trade for the last 12 months.
Is New 90 Day High Low • Sep 22New 90-day low: HK$2.43The company is down 5.0% from its price of HK$2.56 on 24 June 2020. The Hong Kong market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is HK$10.93 per share.